National Center for HIV-AIDS, Viral Hepatitis, STD, and TB Prevention

0
342

Funding Opportunity ID: 313105
Opportunity Number: CDC-RFA-PS19-1907
Opportunity Title: National Center for HIV-AIDS, Viral Hepatitis, STD, and TB Prevention
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
Category Explanation:
CFDA Number(s): 93.977
Eligible Applicants: State governments
Additional Information on Eligibility:
Agency Code: HHS-CDC-NCHHSTP
Agency Name: Department of Health and Human Services
Centers for Disease Control – NCHHSTP
Posted Date: Feb 21, 2019
Close Date: May 15, 2019
Last Updated Date: Feb 21, 2019
Award Ceiling: $600,000
Award Floor: $200,000
Estimated Total Program Funding: $24,000,000
Expected Number of Awards: 10
Description: Three curable bacterial sexually transmitted diseases (STDs): chlamydia (CT), gonorrhea (GC), and syphilis are nationally notifiable and have historically been the focus of federally funded STD prevention programs throughout the U.S. In 2017, 2.3 million cases of these STDs were reported to CDC, reflecting an increase of 35% since 2013[1]. However, these cases do not fully reflect the burden of STDs as many infections are asymptomatic and never diagnosed and reported – and this does not include other STDs that are not nationally notifiable. STDs can have long-term health consequences in addition to the immediate impact on an individual's health. STDs are also an economic burden on the U.S. healthcare system costing billions annually[2]. Persons with STDs are at risk for acquisition or transmission of HIV and represent
Version: 1





Visit the Official Webpage For More Details on National Center for HIV-AIDS, Viral Hepatitis, STD, and TB Prevention

LEAVE A REPLY

Please enter your comment!
Please enter your name here